NVDA
NVIDIA
-- 131.760 TSLA
Tesla
-- 396.360 RGTI
Rigetti Computing
-- 8.9500 AMD
Advanced Micro Devices
-- 116.090 PLTR
Palantir
-- 65.910 
Results next?
$Leap Therapeutics (LPTX.US)$ Leap Therapeutics Concludes Enrollment In The Randomized Controlled Part C Of Distinguish Study Of DKN-01 In Combination With BeiGene's Tislelizumab And Chemotherapy In Patients With Advanced Gastroesophageal Junction And Gastric Cancer
Benzinga· 1 min ago![]()
Benzinga· 1 min ago
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Discussing
Trump 2.0 countdown: What's the next big opportunity in the markets?
▪️Could Trump's cryptocurrency policies potentially benefit the crypto market? ▪️Might his tariff policies have a positive effect on Chinese
Popular on moomoo
Jan 13 17:43
Trump 2.0 Opportunity Preview: Guess the market winner before the president takes office!